RSS   Newsletter   Contact   Advertise with us
Post Online Media

Intercept Pharma appoints Nancy Miller-Rich as director

Nancy Miller-RichIntercept Pharmaceuticals, a clinical stage biopharmaceutical company, announced that it has appointed Nancy Miller-Rich to fill a newly created directorship.
Ms. Miller-Rich has 35 years of experience in the healthcare industry, with significant expertise in business development and commercial strategy.

Ms. Miller-Rich served in a number of leadership roles at Merck & Co., Inc. and, prior to the merger of the two companies, at Schering-Plough Corporation.

This is including most recently as Senior Vice President, Global Human Health Business Development & Licensing, Strategy and Commercial Support (2013 – 2017) and Group Vice President, Consumer Care Global New Ventures and Strategic Commercial Development (2007 – 2013).

Prior to joining Schering-Plough in 1990, Ms. Miller-Rich served in a variety of commercial and marketing roles at Sandoz Pharmaceuticals and Sterling Drug, Inc.

She is currently a director of UDG Healthcare plc, as well as a member of the boards of a number of not-for-profit entities.

 

 LATEST MOVES FROM New York 


 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.